STOCK TITAN

iTonic Holdings (ITOC) Stock News

ITOC NASDAQ

Ticker history: PTHL became ITOC (iTonic Holdings Ltd) on . Earlier news and filings retain their original names and dates. View PTHL history.

iTonic Holdings Ltd reports developments tied to its brachytherapy healthcare-solutions business and its public-company status. Company updates identify Beijing Feitian's Treatment Planning System, related brachytherapy products and services, and the role of its operating subsidiary in cancer-treatment support.

Recurring corporate news also covers Nasdaq listing compliance matters, including minimum bid price requirements for the company's Class A ordinary shares, along with governance, capital-structure and material-event updates reported by the issuer.

Rhea-AI Summary

iTonic Holdings (Nasdaq: ITOC) has regained compliance with Nasdaq’s minimum bid price requirement, closing its previously disclosed bid-price deficiency matter.

A written notice dated October 20, 2026 confirmed compliance with Listing Rule 5550(a)(2). The closing bid price of its Class A ordinary shares was at least US$1.00 for ten consecutive business days, from October 6 through October 19, 2026. The shares began trading on a post-consolidation basis on October 6 following a 16-for-1 share consolidation.

Nasdaq originally notified the company of the deficiency on October 20, 2025. On April 21, 2026, it granted an additional 180-calendar-day compliance period ending October 19, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.21%
Tags
none
-
Rhea-AI Summary

iTonic Holdings (ITOC) will consolidate every 16 shares into one on October 6, 2026, subject to corporate requirements and Nasdaq not objecting. The consolidation covers Class A and Class B shares and takes effect at 12:01 a.m. Eastern Time. Class A shares are expected to begin split-adjusted trading that day.

Outstanding Class A shares will fall from 109,382,000 to approximately 6,836,375; Class B shares will fall from 7,668,000 to approximately 479,250. A related increase will raise authorized capital to US$800,000 without itself increasing outstanding shares. The company intends the consolidation to support regaining compliance with Nasdaq’s US$1.00 minimum bid price requirement by October 19, 2026; compliance is not assured.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.88%
Tags
none
-
Rhea-AI Summary

iTonic Holdings (Nasdaq: ITOC) provided an update on its AI-enabled Treatment Planning System (TPS) Cloud Platform being developed via 60%-owned Mili Medical to support nuclear medicine and radiation treatment planning. The browser-based platform is intended to integrate AI-assisted planning, automated quality control, and standardized data management for multi-location hospital networks.

According to the company, current milestones include core cloud architecture, browser TPS, data-sharing framework, initial AI model training, and quality-control rules. The system is undergoing internal testing and clinical workflow validation, has not been clinically validated or approved by regulators, and is expected to be regulated as medical device software in China.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.29%
Tags
AI
Rhea-AI Summary

iTonic Holdings (NASDAQ: ITOC) received a 180-calendar day extension from Nasdaq to regain compliance with the minimum closing bid price requirement of Nasdaq Listing Rule 5550(a)(2). The new deadline is October 19, 2026, after the initial 180-day compliance period expired on April 20, 2026. If compliance is not achieved by October 19, Nasdaq will notify the company that its Class A ordinary shares will be delisted; the company may then request a review by a Nasdaq Hearings Panel.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.83%
Tags
none

FAQ

What is the current stock price of iTonic Holdings (ITOC)?

iTonic Holdings (ITOC) last closed at $1.98.

What is the market cap of iTonic Holdings (ITOC)?

The market cap of iTonic Holdings (ITOC) is approximately $14.5M.